ALMOTRIPTAN MALATE vs ALPELISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ALMOTRIPTAN MALATE vs ALPELISIB: Safety Overview
| Metric | ALMOTRIPTAN MALATE | ALPELISIB |
|---|---|---|
| Total FAERS Reports | 497 | 8,419 |
| Deaths Reported | 3 | 1,271 |
| Death Rate | 0.6% | 15.1% |
| Hospitalizations | 60 | 1,705 |
| Average Patient Age | 52.4 yrs | 58.8 yrs |
| % Female Patients | 16.5% | 94.7% |
| FDA Approval Date | Jul 7, 2015 | Apr 24, 2024 |
| Manufacturer | Mylan Pharmaceuticals Inc. | Novartis Pharmaceuticals Corporation |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |